Elekta AB (LTS:0O5H) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0O5H Elekta AB LTS:0O5H
71 GF Score
Price kr54.55
GF Value kr57.76
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Elekta AB Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

LTS:0O5H
71GF Score
Elekta AB LTS:0O5H
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Elekta AB (LTS:0O5H) Overvalued in 2026?

Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued. The current stock price of kr54.55 is trading 5.6% below its estimated GF Value™ of kr57.76. GuruFocus considers Elekta AB to be Fairly Valued.

Key valuation signals for LTS:0O5H:

  • Interest Received:
  • GF Value™: kr57.76 vs. price of kr54.55 (5.6% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the LTS:0O5H stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elekta AB Business Description

Address Hagaplan 4, Box 7593, Stockholm, SWE, 11368
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
71GF Score

Get the complete analysis for LTS:0O5H

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr54.55
Price
kr57.76
GF Value